ARCHIVES

NIH Reauthorization Compromise Between House and Senate Gives NCI Three Year Authorization Period

This article is from The Cancer Letter archive.

Vol. 11 No. 40 | October 18, 1985

Download PDF Visit The Full Archive

Related Articles

NCI director says rules hurt retention, recruitment, cites Liotta’s departure.

April 8, 2005

NCAB Approves Fallout Study On Split Vote

March 13, 1981

Funding Opportunities: NCI Offers Funds To Develop, Validate Mouse Models

November 20, 1998

FDA Advisors Give Dox-SL Conditional Approval; Ok Zoladex

February 24, 1995

DCE Publishes Lister of Resources Available To Scientific Community

November 9, 1984

Zometa Reduced Bone Complications In Patients With Prostate Cancer Bone Mets

October 25, 2002